Hudson Institute has a focus on the translation of our research to deliver health benefits to the community.
We have a number of opportunities available for collaboration, investment, and licensing, to enable the development and commercialisation of our research and technologies.
Below are examples of technologies developed by Hudson Institute researchers. Contact us if you are interested in these, or if you have specific area you would like to pursue.
|Wound healing and skin repair||Hudson researchers have identified unique factors that promote the healing of skin, by promoting cellular adhesion and migration of skin cells to the site needing repair.|
|Improving IVF outcomes: Assessing endometrial receptivity||Our researchers are developing a simple blood test to predict the likelihood of a successful IVF embryo transfer, so clinicians and patients can make informed decisions about treatment.|
|A novel target for treatment of Parkinson’s disease||Our team have identified a male-specific factor that may underlie the sex-based bias of Parkinson’s and influence development of disease in men.|
|Small molecule inhibitors of liver receptor homolog-1 (LRH-1)||In partnership with St Vincent’s Institute, our researchers have identified a lead series inhibiting LRH-1, aberrant expression of which is associated with a range of cancers.|
For more information on any of our projects, contact Rob Merriel, Chief Commercialisation Officer.